Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 16, Issue 5, Pages 541-553
Publisher
Future Medicine Ltd
Online
2015-04-28
DOI
10.2217/pgs.15.15
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between the TPH1 A218C polymorphism and antidepressant response
- (2015) Xiaofeng Zhao et al. PSYCHIATRIC GENETICS
- Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression
- (2014) Alberto Chiesa et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Escitalopram Efficacy in Depression
- (2014) Chad A. Bousman et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Major Depression
- (2014) Susan M. Bentley et al. MEDICAL CLINICS OF NORTH AMERICA
- SLC6A4 Polymorphisms and Age of Onset in Late-life Depression on Treatment Outcomes with Citalopram: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Report
- (2013) Paulo R. Shiroma et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression
- (2013) Chee Ng et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
- (2013) Daniel K. Hall-Flavin et al. Pharmacogenetics and Genomics
- Pharmacogenetics in major depression: A comprehensive meta-analysis
- (2013) Tomihisa Niitsu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression
- (2013) Alessandro Serretti et al. Psychiatry Investigation
- Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder
- (2013) Seth C. Hopkins et al. PSYCHIATRY RESEARCH
- Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
- (2013) J Winner et al. Translational Psychiatry
- TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression
- (2012) Bárbara Arias et al. NEUROPSYCHOBIOLOGY
- Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder
- (2012) F W Lohoff et al. PHARMACOGENOMICS JOURNAL
- Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder
- (2012) Sneha Narasimhan et al. PSYCHIATRY RESEARCH
- Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
- (2011) Stefano Porcelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response
- (2011) Zhi Xu et al. JOURNAL OF AFFECTIVE DISORDERS
- Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder
- (2011) F W Lohoff et al. PHARMACOGENOMICS JOURNAL
- Functional psychopharmacology is the way to go in pharmacotherapy for psychiatric disorders
- (2010) Anton J. M. Loonen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
- (2010) Rudolf Uher et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
- (2010) Matthew J. Taylor et al. BIOLOGICAL PSYCHIATRY
- Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine
- (2010) F. Benedetti et al. EUROPEAN PSYCHIATRY
- Relation of Serotonin Transporter Genetic Variation to Efficacy of Escitalopram for Generalized Anxiety Disorder in Older Adults
- (2010) Eric J. Lenze et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients
- (2010) Hsuan-Chi Wang et al. PSYCHOPHARMACOLOGY
- Overview of the Genetics of Major Depressive Disorder
- (2010) Falk W. Lohoff Current Psychiatry Reports
- A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
- (2009) Marcus Ising et al. ARCHIVES OF GENERAL PSYCHIATRY
- A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
- (2009) Holly A. Garriock et al. BIOLOGICAL PSYCHIATRY
- Moderation of antidepressant response by the serotonin transporter gene
- (2009) Patricia Huezo-Diaz et al. BRITISH JOURNAL OF PSYCHIATRY
- HTR2A gene variation is involved in antidepressant treatment response
- (2009) Susanne Lucae et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- MAOA gene polymorphisms and response to mirtazapine in major depression
- (2009) Dong-Sheng Tzeng et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder
- (2009) Andrew F. Leuchter et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Pharmacogenetics of anxiolytic drugs
- (2009) Arun K. Tiwari et al. JOURNAL OF NEURAL TRANSMISSION
- Polymorphisms in GRIK4, HTR2A and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment
- (2009) Sonja Horstmann et al. NEUROPSYCHOPHARMACOLOGY
- Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment
- (2009) Mladen Vassilev Tzvetkov et al. Pharmacogenetics and Genomics
- Genetic predictors of response to antidepressants in the GENDEP project
- (2009) Rudolf Uher et al. PHARMACOGENOMICS JOURNAL
- Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response
- (2009) Shih-Jen Tsai et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- SLC6A4 variation and citalopram response
- (2008) D.A. Mrazek et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder
- (2008) Masaki Kato et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder
- (2008) Roy H. Perlis et al. BIOLOGICAL PSYCHIATRY
- Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients
- (2008) Shih-Jen Tsai et al. JOURNAL OF AFFECTIVE DISORDERS
- Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
- (2008) M Kato et al. MOLECULAR PSYCHIATRY
- Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response
- (2008) Eric J. Peters et al. Pharmacogenetics and Genomics
- Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy
- (2008) M J V Wilkie et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
- (2008) Felix W Frueh et al. PHARMACOTHERAPY
- The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
- (2008) Francesco Benedetti et al. PSYCHOPHARMACOLOGY
- Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
- (2007) Keizo Yoshida et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea
- (2007) Misuzu Tanaka et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression
- (2007) Katharina Domschke et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More